{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:20:38Z","timestamp":1775042438673,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15716-w","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T01:42:58Z","timestamp":1771206178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IL-8 positive cancer-associated fibroblasts drive breast cancer progression and immune evasion: insights from GWAS and single-cell transcriptomics"],"prefix":"10.1186","volume":"26","author":[{"given":"Huifeng","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huayan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyu","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liling","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peixian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiancheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"issue":"3","key":"15716_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"15716_CR2","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/cac2.12207","volume":"41","author":"S Lei","year":"2021","unstructured":"Lei S, Zheng R, Zhang S, Wang S, Chen R, Sun K, Zeng H, Zhou J, Wei W. Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020. Cancer Commun (London England). 2021;41(11):1183\u201394.","journal-title":"Cancer Commun (London England)"},{"issue":"8","key":"15716_CR3","doi-asserted-by":"publisher","first-page":"e1027","DOI":"10.1016\/S2214-109X(20)30215-1","volume":"8","author":"E Heer","year":"2020","unstructured":"Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Global Health. 2020;8(8):e1027\u201337.","journal-title":"Lancet Global Health"},{"issue":"1","key":"15716_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13045-025-01688-0","volume":"18","author":"H Jia","year":"2025","unstructured":"Jia H, Chen X, Zhang L, Chen M. Cancer associated fibroblasts in cancer development and therapy. J Hematol Oncol. 2025;18(1):36.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"15716_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s13046-024-03251-0","volume":"43","author":"K Raaijmakers","year":"2024","unstructured":"Raaijmakers K, Adema GJ, Bussink J, Ansems M. Cancer-associated fibroblasts, tumor and radiotherapy: interactions in the tumor micro-environment. J Experimental Clin Cancer Research: CR. 2024;43(1):323.","journal-title":"J Experimental Clin Cancer Research: CR"},{"key":"15716_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jare.2024.05.031","volume":"71","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhang X, Gu W, Su H, Wang X, Wang X, Zhang J, Xu M, Sheng W. Unlocking the crucial role of cancer-associated fibroblasts in tumor metastasis: mechanisms and therapeutic prospects. J Adv Res. 2025;71:399\u2013413.","journal-title":"J Adv Res"},{"issue":"1","key":"15716_CR7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12943-022-01670-1","volume":"21","author":"M Xu","year":"2022","unstructured":"Xu M, Zhang T, Xia R, Wei Y, Wei X. Targeting the tumor stroma for cancer therapy. Mol Cancer. 2022;21(1):208.","journal-title":"Mol Cancer"},{"issue":"1","key":"15716_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, Zhang B, Meng Q, Yu X, Shi S. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20(1):131.","journal-title":"Mol Cancer"},{"issue":"1","key":"15716_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12943-021-01463-y","volume":"20","author":"C Li","year":"2021","unstructured":"Li C, Teixeira AF, Zhu HJ, Ten Dijke P. Cancer associated-fibroblast-derived exosomes in cancer progression. Mol Cancer. 2021;20(1):154.","journal-title":"Mol Cancer"},{"issue":"5","key":"15716_CR10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.trecan.2023.01.007","volume":"9","author":"L Arpinati","year":"2023","unstructured":"Arpinati L, Scherz-Shouval R. From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts. Trends Cancer. 2023;9(5):421\u201343.","journal-title":"Trends Cancer"},{"issue":"9","key":"15716_CR11","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1158\/1078-0432.CCR-20-1319","volume":"27","author":"A Teijeira","year":"2021","unstructured":"Teijeira A, Garasa S, Ochoa MC, Villalba M, Olivera I, Cirella A, Eguren-Santamaria I, Berraondo P, Schalper KA, de Andrea CE, et al. IL-8, Neutrophils, and NETs in a collusion against cancer immunity and immunotherapy. Clin Cancer Research: Official J Am Association Cancer Res. 2021;27(9):2383\u201393.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"1","key":"15716_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12964-023-01068-6","volume":"21","author":"M Wu","year":"2023","unstructured":"Wu M, Zhang X, Zhang W, Yan L, Liu X, Zhang M, Pan Y, Lobie PE, Han X, Zhu T. Paracrine secretion of IL-8 by breast cancer stem cells promotes therapeutic resistance and metastasis of the bulk tumor cells. Cell Communication Signaling: CCS. 2023;21(1):59.","journal-title":"Cell Communication Signaling: CCS"},{"key":"15716_CR13","doi-asserted-by":"publisher","first-page":"107692","DOI":"10.1016\/j.pharmthera.2020.107692","volume":"219","author":"K Fousek","year":"2021","unstructured":"Fousek K, Horn LA, Palena C. Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression. Pharmacol Ther. 2021;219:107692.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"15716_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1158\/0008-5472.CAN-21-1446","volume":"82","author":"Y Xu","year":"2022","unstructured":"Xu Y, Ren W, Li Q, Duan C, Lin X, Bi Z, You K, Hu Q, Xie N, Yu Y, et al. LncRNA Uc003xsl.1-Mediated activation of the NF\u03baB\/IL-8 axis promotes progression of Triple-Negative breast cancer. Cancer Res. 2022;82(4):556\u201370.","journal-title":"Cancer Res"},{"key":"15716_CR15","doi-asserted-by":"publisher","first-page":"110194","DOI":"10.1016\/j.intimp.2023.110194","volume":"119","author":"H Liao","year":"2023","unstructured":"Liao H, Li H, Dong J, Song J, Chen H, Si H, Wang J, Bai X. Melatonin blunts the tumor-promoting effect of cancer-associated fibroblasts by reducing IL-8 expression and reversing epithelial-mesenchymal transition. Int Immunopharmacol. 2023;119:110194.","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"15716_CR16","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1158\/0008-5472.CAN-15-2511","volume":"76","author":"E Shoshan","year":"2016","unstructured":"Shoshan E, Braeuer RR, Kamiya T, Mobley AK, Huang L, Vasquez ME, Velazquez-Torres G, Chakravarti N, Ivan C, Prieto V, et al. NFAT1 directly regulates IL-8 and MMP3 to promote melanoma tumor growth and metastasis. Cancer Res. 2016;76(11):3145\u201355.","journal-title":"Cancer Res"},{"issue":"1","key":"15716_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s13046-019-1423-5","volume":"38","author":"Y Wang","year":"2019","unstructured":"Wang Y, Zhao M, He S, Luo Y, Zhao Y, Cheng J, Gong Y, Xie J, Wang Y, Hu B, et al. Necroptosis regulates tumor repopulation after radiotherapy via RIP1\/RIP3\/MLKL\/JNK\/IL-8 pathway. J Experimental Clin Cancer Research: CR. 2019;38(1):461.","journal-title":"J Experimental Clin Cancer Research: CR"},{"key":"15716_CR18","doi-asserted-by":"publisher","unstructured":"GaoM, Wu X, Jiao X, Hu Y, Wang Y, Zhuo N, Dong F, Wang Y, Wang F, Cao Y, et al. Prognostic and predictive value of angiogenesis-associated serum proteins for immunotherapy in esophageal cancer. J Immunother Cancer. 2024;12(2). https:\/\/doi.org\/10.1136\/jitc-2022-006616.","DOI":"10.1136\/jitc-2022-006616"},{"key":"15716_CR19","doi-asserted-by":"publisher","unstructured":"HanZJ, Li YB, Yang LX, Cheng HJ, Liu X, Chen H. Roles of the CXCL8-CXCR1\/2 axis in the tumor microenvironment and immunotherapy. Molecules. 2021;27(1). https:\/\/doi.org\/10.3390\/molecules27010137.","DOI":"10.3390\/molecules27010137"},{"issue":"1","key":"15716_CR20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s13046-019-1455-x","volume":"38","author":"F Sun","year":"2019","unstructured":"Sun F, Wang J, Sun Q, Li F, Gao H, Xu L, Zhang J, Sun X, Tian Y, Zhao Q, et al. Interleukin-8 promotes integrin \u03b23 upregulation and cell invasion through PI3K\/Akt pathway in hepatocellular carcinoma. J Experimental Clin Cancer Research: CR. 2019;38(1):449.","journal-title":"J Experimental Clin Cancer Research: CR"},{"issue":"2","key":"15716_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.canlet.2015.05.009","volume":"364","author":"N Shao","year":"2015","unstructured":"Shao N, Lu Z, Zhang Y, Wang M, Li W, Hu Z, Wang S, Lin Y. Interleukin-8 upregulates integrin \u03b23 expression and promotes Estrogen receptor-negative breast cancer cell invasion by activating the PI3K\/Akt\/NF-\u03baB pathway. Cancer Lett. 2015;364(2):165\u201372.","journal-title":"Cancer Lett"},{"issue":"12","key":"15716_CR22","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1007\/s00262-022-03223-3","volume":"71","author":"X Li","year":"2022","unstructured":"Li X, Zhai J, Shen Y, Zhang T, Wang Y, He Y, You Q, Shen L. Tumor-derived IL-8 facilitates lymph node metastasis of gastric cancer via PD-1 up-regulation in CD8(+) T cells. Cancer Immunol Immunotherapy: CII. 2022;71(12):3057\u201370.","journal-title":"Cancer Immunol Immunotherapy: CII"},{"issue":"7","key":"15716_CR23","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s43018-022-00411-z","volume":"3","author":"D Lavie","year":"2022","unstructured":"Lavie D, Ben-Shmuel A, Erez N, Scherz-Shouval R. Cancer-associated fibroblasts in the single-cell era. Nat Cancer. 2022;3(7):793\u2013807.","journal-title":"Nat Cancer"},{"issue":"4","key":"15716_CR24","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jcmgh.2023.07.001","volume":"16","author":"J Huang","year":"2023","unstructured":"Huang J, Tsang WY, Li ZH, Guan XY. The Origin, Differentiation, and functions of cancer-Associated fibroblasts in Gastrointestinal cancer. Cell Mol Gastroenterol Hepatol. 2023;16(4):503\u201311.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"15716_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13059-020-02248-0","volume":"22","author":"MS Lyon","year":"2021","unstructured":"Lyon MS, Andrews SJ, Elsworth B, Gaunt TR, Hemani G, Marcora E. The variant call format provides efficient and robust storage of GWAS summary statistics. Genome Biol. 2021;22(1):32.","journal-title":"Genome Biol"},{"issue":"12","key":"15716_CR26","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, Gunnarsdottir K, Helgason A, Oddsson A, Halldorsson BV, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021;53(12):1712\u201321.","journal-title":"Nat Genet"},{"key":"15716_CR27","doi-asserted-by":"publisher","unstructured":"JooEH, Kim S, Park D, Lee T, Park WY, Han KY, Lee JE. Migratory tumor cells cooperate with cancer associated fibroblasts in hormone Receptor-Positive and HER2-Negative breast cancer. Int J Mol Sci. 2024;25(11). https:\/\/doi.org\/10.3390\/ijms25115876.","DOI":"10.3390\/ijms25115876"},{"issue":"9","key":"15716_CR28","doi-asserted-by":"publisher","first-page":"100383","DOI":"10.1016\/j.xgen.2023.100383","volume":"3","author":"Y Ma","year":"2023","unstructured":"Ma Y, Deng C, Zhou Y, Zhang Y, Qiu F, Jiang D, Zheng G, Li J, Shuai J, Zhang Y, et al. Polygenic regression uncovers trait-relevant cellular contexts through pathway activation transformation of single-cell RNA sequencing data. Cell Genomics. 2023;3(9):100383.","journal-title":"Cell Genomics"},{"issue":"4","key":"15716_CR29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s43018-022-00356-3","volume":"3","author":"T Chu","year":"2022","unstructured":"Chu T, Wang Z, Pe\u2019er D, Danko CG. Cell type and gene expression Deconvolution with bayesprism enables bayesian integrative analysis across bulk and single-cell RNA sequencing in oncology. Nat Cancer. 2022;3(4):505\u201317.","journal-title":"Nat Cancer"},{"issue":"11","key":"15716_CR30","doi-asserted-by":"publisher","first-page":"113424","DOI":"10.1016\/j.celrep.2023.113424","volume":"42","author":"F Xu","year":"2023","unstructured":"Xu F, Wang X, Huang Y, Zhang X, Sun W, Du Y, Xu Z, Kou H, Zhu S, Liu C, et al. Prostate cancer cell-derived Exosomal IL-8 fosters immune evasion by disturbing glucolipid metabolism of CD8(+) T cell. Cell Rep. 2023;42(11):113424.","journal-title":"Cell Rep"},{"issue":"9","key":"15716_CR31","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1038\/s41416-020-1026-0","volume":"123","author":"M Yang","year":"2020","unstructured":"Yang M, Zhang G, Wang Y, He M, Xu Q, Lu J, Liu H, Xu C. Tumour-associated neutrophils orchestrate intratumoural IL-8-driven immune evasion through Jagged2 activation in ovarian cancer. Br J Cancer. 2020;123(9):1404\u201316.","journal-title":"Br J Cancer"},{"issue":"23","key":"15716_CR32","doi-asserted-by":"publisher","first-page":"5876","DOI":"10.1158\/0008-5472.CAN-21-1456","volume":"81","author":"F Dong","year":"2021","unstructured":"Dong F, Qin X, Wang B, Li Q, Hu J, Cheng X, Guo D, Cheng F, Fang C, Tan Y, et al. ALKBH5 facilitates Hypoxia-Induced paraspeckle assembly and IL-8 secretion to generate an immunosuppressive tumor microenvironment. Cancer Res. 2021;81(23):5876\u201388.","journal-title":"Cancer Res"},{"issue":"10","key":"15716_CR33","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, Li Z, Traugh N, Bu X, Li B, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138.","journal-title":"Nat Med"},{"issue":"5","key":"15716_CR34","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2628","volume":"9","author":"F Balkwill","year":"2009","unstructured":"Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009;9(5):361\u201371.","journal-title":"Nat Rev Cancer"},{"key":"15716_CR35","doi-asserted-by":"publisher","unstructured":"DiazArguello OA, Haisma HJ. Apoptosis-Inducing TNF superfamily ligands for cancer therapy. Cancers (Basel). 2021;13(7). https:\/\/doi.org\/10.3390\/cancers13071543.","DOI":"10.3390\/cancers13071543"},{"issue":"2","key":"15716_CR36","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1158\/0008-5472.CAN-21-1171","volume":"82","author":"W Liu","year":"2022","unstructured":"Liu W, Stachura P, Xu HC, V\u00e1raljai R, Shinde P, Ganesh NU, Mack M, Van Lierop A, Huang A, Sundaram B, et al. BAFF attenuates immunosuppressive monocytes in the melanoma tumor microenvironment. Cancer Res. 2022;82(2):264\u201377.","journal-title":"Cancer Res"},{"key":"15716_CR37","doi-asserted-by":"publisher","first-page":"713757","DOI":"10.3389\/fimmu.2021.713757","volume":"12","author":"R Chen","year":"2021","unstructured":"Chen R, Wang X, Dai Z, Wang Z, Wu W, Hu Z, Zhang X, Liu Z, Zhang H, Cheng Q. TNFSF13 is a novel Onco-Inflammatory marker and correlates with immune infiltration in gliomas. Front Immunol. 2021;12:713757.","journal-title":"Front Immunol"},{"key":"15716_CR38","doi-asserted-by":"publisher","unstructured":"UllahMA, Mackay F. The BAFF-APRIL system in cancer. Cancers (Basel). 2023;15(6). https:\/\/doi.org\/10.3390\/cancers15061791.","DOI":"10.3390\/cancers15061791"},{"key":"15716_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2023.10.004","volume":"97","author":"X Wang","year":"2023","unstructured":"Wang X, Eichhorn PJA, Thiery JP. TGF-\u03b2, EMT, and resistance to anti-cancer treatment. Sem Cancer Biol. 2023;97:1\u201311.","journal-title":"Sem Cancer Biol"},{"key":"15716_CR40","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev-immunol-101921-045939","volume":"41","author":"W Chen","year":"2023","unstructured":"Chen W. TGF-\u03b2 regulation of T cells. Annu Rev Immunol. 2023;41:483\u2013512.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"15716_CR41","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1038\/s41467-022-31250-2","volume":"13","author":"F Xie","year":"2022","unstructured":"Xie F, Zhou X, Su P, Li H, Tu Y, Du J, Pan C, Wei X, Zheng M, Jin K, et al. Breast cancer cell-derived extracellular vesicles promote CD8(+) T cell exhaustion via TGF-\u03b2 type II receptor signaling. Nat Commun. 2022;13(1):4461.","journal-title":"Nat Commun"},{"issue":"415","key":"15716_CR42","doi-asserted-by":"publisher","first-page":"ra19","DOI":"10.1126\/scisignal.aad1884","volume":"9","author":"S Viel","year":"2016","unstructured":"Viel S, Mar\u00e7ais A, Guimaraes FS, Loftus R, Rabilloud J, Grau M, Degouve S, Djebali S, Sanlaville A, Charrier E, et al. TGF-\u03b2 inhibits the activation and functions of NK cells by repressing the mTOR pathway. Sci Signal. 2016;9(415):ra19.","journal-title":"Sci Signal"},{"issue":"6","key":"15716_CR43","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1042\/BST20180136","volume":"46","author":"MY Taher","year":"2018","unstructured":"Taher MY, Davies DM, Maher J. The role of the Interleukin (IL)-6\/IL-6 receptor axis in cancer. Biochem Soc Trans. 2018;46(6):1449\u201362.","journal-title":"Biochem Soc Trans"},{"issue":"26","key":"15716_CR44","doi-asserted-by":"publisher","first-page":"7492","DOI":"10.1016\/j.cell.2024.10.006","volume":"187","author":"G Mollaoglu","year":"2024","unstructured":"Mollaoglu G, Tepper A, Falcomat\u00e0 C, Potak HT, Pia L, Amabile A, Mateus-Tique J, Rabinovich N, Park MD, LaMarche NM, et al. Ovarian cancer-derived IL-4 promotes immunotherapy resistance. Cell. 2024;187(26):7492\u2013e75107422.","journal-title":"Cell"},{"issue":"4","key":"15716_CR45","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jhep.2023.12.015","volume":"80","author":"AM Shiri","year":"2024","unstructured":"Shiri AM, Zhang T, Bedke T, Zazara DE, Zhao L, L\u00fccke J, Sabihi M, Fazio A, Zhang S, Tauriello DVF, et al. IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction. J Hepatol. 2024;80(4):634\u201344.","journal-title":"J Hepatol"},{"issue":"6","key":"15716_CR46","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.7150\/thno.15625","volume":"7","author":"H Ha","year":"2017","unstructured":"Ha H, Debnath B, Neamati N. Role of the CXCL8-CXCR1\/2 axis in cancer and inflammatory diseases. Theranostics. 2017;7(6):1543\u201388.","journal-title":"Theranostics"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15716-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15716-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15716-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:49:18Z","timestamp":1775036958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15716-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15716"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15716-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the First People\u2019s Hospital of Foshan (2320001006552). Written informed consent was obtained from all participants. The patient was pathologically diagnosed as primary breast cancer, and the postoperative specimens were collected during 2023\u20132024.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"434"}}